Nontumorous arterioportal shunts in the liver

CT and MRI findings considering mechanisms and fate

Jhii Hyun Ahn, Jeong Sik Yu, Sung Ho Hwang, Jae Joon Chung, Joo Hee Kim, Ki Whang Kim

Research output: Contribution to journalReview article

45 Citations (Scopus)

Abstract

The intrahepatic non-tumorous arterioportal shunt (APS) is one of the important causes of transient hepatic enhancement differences (THED) on dynamic CTor MRI. Most small APSs are located in the peripheral portion of the liver. Because of the parenchymal distortion in the advanced cirrhotic liver, many small APSs tend to show an amorphous or nodular appearance, making them difficult to distinguish from hypervascular tumors. In addition to the use of dynamic CT or MRI, isoattenuation densities or iso-intensities on pre-contrast and equilibrium phases, MRI using a liver-specific contrast agent can be useful to characterize the hypervascular pseudolesions. Because there is no difference in water diffusion in the hepatic parenchyma in the region of the APS, diffusion-weighted MRI also has great potential to distinguish non-tumorous shunts from true focal lesions. Larger (>2 cm) APSs of direct arterio-portal venous fistulas from extrinsic insults show typical subcapsular wedge-like THEDs that are only temporarily depicted several months after the traumatic event; most of these THEDs gradually decrease in size or vanish completely. By understanding the nature of non-tumorous APSs, radiologists will be able to provide a more accurate assessment of many THEDs during daily interpretations of CT or MR images of the liver.

Original languageEnglish
Pages (from-to)385-394
Number of pages10
JournalEuropean Radiology
Volume20
Issue number2
DOIs
Publication statusPublished - 2010 Feb 1
Externally publishedYes

Fingerprint

Liver
Diffusion Magnetic Resonance Imaging
Contrast Media
Fistula
Water
Neoplasms

Keywords

  • Arterio-portal shunts
  • Contrast agent
  • CT
  • Diffusion-weighted imaging
  • Magnetic resonance (MR)

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Nontumorous arterioportal shunts in the liver : CT and MRI findings considering mechanisms and fate. / Ahn, Jhii Hyun; Yu, Jeong Sik; Hwang, Sung Ho; Chung, Jae Joon; Kim, Joo Hee; Kim, Ki Whang.

In: European Radiology, Vol. 20, No. 2, 01.02.2010, p. 385-394.

Research output: Contribution to journalReview article

Ahn, Jhii Hyun ; Yu, Jeong Sik ; Hwang, Sung Ho ; Chung, Jae Joon ; Kim, Joo Hee ; Kim, Ki Whang. / Nontumorous arterioportal shunts in the liver : CT and MRI findings considering mechanisms and fate. In: European Radiology. 2010 ; Vol. 20, No. 2. pp. 385-394.
@article{bd1d646b40054e3f8b5bd3b7757eb246,
title = "Nontumorous arterioportal shunts in the liver: CT and MRI findings considering mechanisms and fate",
abstract = "The intrahepatic non-tumorous arterioportal shunt (APS) is one of the important causes of transient hepatic enhancement differences (THED) on dynamic CTor MRI. Most small APSs are located in the peripheral portion of the liver. Because of the parenchymal distortion in the advanced cirrhotic liver, many small APSs tend to show an amorphous or nodular appearance, making them difficult to distinguish from hypervascular tumors. In addition to the use of dynamic CT or MRI, isoattenuation densities or iso-intensities on pre-contrast and equilibrium phases, MRI using a liver-specific contrast agent can be useful to characterize the hypervascular pseudolesions. Because there is no difference in water diffusion in the hepatic parenchyma in the region of the APS, diffusion-weighted MRI also has great potential to distinguish non-tumorous shunts from true focal lesions. Larger (>2 cm) APSs of direct arterio-portal venous fistulas from extrinsic insults show typical subcapsular wedge-like THEDs that are only temporarily depicted several months after the traumatic event; most of these THEDs gradually decrease in size or vanish completely. By understanding the nature of non-tumorous APSs, radiologists will be able to provide a more accurate assessment of many THEDs during daily interpretations of CT or MR images of the liver.",
keywords = "Arterio-portal shunts, Contrast agent, CT, Diffusion-weighted imaging, Magnetic resonance (MR)",
author = "Ahn, {Jhii Hyun} and Yu, {Jeong Sik} and Hwang, {Sung Ho} and Chung, {Jae Joon} and Kim, {Joo Hee} and Kim, {Ki Whang}",
year = "2010",
month = "2",
day = "1",
doi = "10.1007/s00330-009-1542-z",
language = "English",
volume = "20",
pages = "385--394",
journal = "European Radiology",
issn = "0938-7994",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Nontumorous arterioportal shunts in the liver

T2 - CT and MRI findings considering mechanisms and fate

AU - Ahn, Jhii Hyun

AU - Yu, Jeong Sik

AU - Hwang, Sung Ho

AU - Chung, Jae Joon

AU - Kim, Joo Hee

AU - Kim, Ki Whang

PY - 2010/2/1

Y1 - 2010/2/1

N2 - The intrahepatic non-tumorous arterioportal shunt (APS) is one of the important causes of transient hepatic enhancement differences (THED) on dynamic CTor MRI. Most small APSs are located in the peripheral portion of the liver. Because of the parenchymal distortion in the advanced cirrhotic liver, many small APSs tend to show an amorphous or nodular appearance, making them difficult to distinguish from hypervascular tumors. In addition to the use of dynamic CT or MRI, isoattenuation densities or iso-intensities on pre-contrast and equilibrium phases, MRI using a liver-specific contrast agent can be useful to characterize the hypervascular pseudolesions. Because there is no difference in water diffusion in the hepatic parenchyma in the region of the APS, diffusion-weighted MRI also has great potential to distinguish non-tumorous shunts from true focal lesions. Larger (>2 cm) APSs of direct arterio-portal venous fistulas from extrinsic insults show typical subcapsular wedge-like THEDs that are only temporarily depicted several months after the traumatic event; most of these THEDs gradually decrease in size or vanish completely. By understanding the nature of non-tumorous APSs, radiologists will be able to provide a more accurate assessment of many THEDs during daily interpretations of CT or MR images of the liver.

AB - The intrahepatic non-tumorous arterioportal shunt (APS) is one of the important causes of transient hepatic enhancement differences (THED) on dynamic CTor MRI. Most small APSs are located in the peripheral portion of the liver. Because of the parenchymal distortion in the advanced cirrhotic liver, many small APSs tend to show an amorphous or nodular appearance, making them difficult to distinguish from hypervascular tumors. In addition to the use of dynamic CT or MRI, isoattenuation densities or iso-intensities on pre-contrast and equilibrium phases, MRI using a liver-specific contrast agent can be useful to characterize the hypervascular pseudolesions. Because there is no difference in water diffusion in the hepatic parenchyma in the region of the APS, diffusion-weighted MRI also has great potential to distinguish non-tumorous shunts from true focal lesions. Larger (>2 cm) APSs of direct arterio-portal venous fistulas from extrinsic insults show typical subcapsular wedge-like THEDs that are only temporarily depicted several months after the traumatic event; most of these THEDs gradually decrease in size or vanish completely. By understanding the nature of non-tumorous APSs, radiologists will be able to provide a more accurate assessment of many THEDs during daily interpretations of CT or MR images of the liver.

KW - Arterio-portal shunts

KW - Contrast agent

KW - CT

KW - Diffusion-weighted imaging

KW - Magnetic resonance (MR)

UR - http://www.scopus.com/inward/record.url?scp=77951230479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951230479&partnerID=8YFLogxK

U2 - 10.1007/s00330-009-1542-z

DO - 10.1007/s00330-009-1542-z

M3 - Review article

VL - 20

SP - 385

EP - 394

JO - European Radiology

JF - European Radiology

SN - 0938-7994

IS - 2

ER -